Packer L, Kraemer K, Rimbach G
typically dose-related and diminishing over time Serious risks : Pancreatitis (rare), gallbladder events, thyroid C-cell tumor boxed warning (from rodent studies) Dose escalation : Slow titration (0.25 mg escalating monthly) mitigates GI tolerability Strength : The safety database is massive, with well-defined risk-benefit profile across multiple patient populations Survodutide Side Effects# Less well-characterized with limited clinical exposure: GI effects : Expected GLP-1 class effects (nausea, vomiting, diarrhea) observed in Phase 2 Glucagon-specific concerns : Potential for hepatic glucose output increase (mitigated by GLP-1 component), theoretical impact on blood glucose in diabetic populations Heart rate : Glucagon receptor agonism may affect heart rate
Treats zinc deficiency Zinc supplements are often used to help treat and prevent zinc deficiency
The leading and most diverse group of GSTs are the cytosolic enzyme spresent in humans
Can you get a false positive pregnancy test
The specifics will depend partly on whether the plan is self-insured, or purchased by the employer in the large-group or small-group market
